GSK Consumer Healthcare appoints new CEO

Brian McNamara

Brian McNamara has been appointed Chief Executive Officer of GSK’s Consumer Healthcare division.

He succeeds Emma Walmsley, who was appointed GSK CEO designate, succeeding Sir Andrew Witty as GSK CEO. In his new role, Mr McNamara will report to Andrew Witty until Emma becomes CEO. He will join GSK’s corporate executive team effective immediately and will continue as a member of the board of the Consumer Healthcare Joint Venture with Novartis. He will be based in the UK.

Mr McNamara is currently head of Europe and Americas at GSK Consumer Healthcare. He joined GSK from Novartis following completion of GSK’s three-part transaction with Novartis and has been a member of GSK’s Consumer Healthcare Executive Team since 2015.

Prior to joining GSK, Mr McNamara spent 11 years at Novartis and 16 years at Procter & Gamble. He said: “I am very excited about the opportunity to lead the Consumer Healthcare business at GSK. We have an amazing opportunity ahead of us to deliver on our promise to consumers and grow our business to further extend our position as a leading, global consumer healthcare company”.

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.